Annual report pursuant to Section 13 and 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.22.4
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Assets and liabilities measured at fair value on a recurring basis
The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions):
December 31, 2022
Level 1 Level 2 Level 3
Other3
Netting
Adjustment
4
Fair Value
Measurements
Assets:          
Equity securities with readily determinable values1
$ 1,801  $ 169  $ 15  $ 85  $ —  $ 2,070 
Debt securities1
—  975  —  —  983 
Derivatives2
239  —  —  (227)
6
14 
8
Total assets $ 1,803  $ 1,383  $ 23  $ 85  $ (227) $ 3,067 
Liabilities:          
Contingent consideration liability $ —  $ —  $ 1,590 
5
$ —  $ —  $ 1,590 
Derivatives2
1,962  —  —  (1,678)
7
288 
8
Total liabilities $ $ 1,962  $ 1,590  $ —  $ (1,678) $ 1,878 
1Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
2Refer to Note 5 for additional information related to the composition of our derivatives portfolio.
3Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
4Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.
5Refer to Note 2 for additional information related to the contingent consideration liability resulting from the fairlife acquisition.
6The Company is not obligated to return any cash collateral it has netted against its derivative position.
7The Company has the right to reclaim $1,447 million in cash collateral it has netted against its derivative position.
8The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $14 million in the line item other noncurrent assets and $288 million in the line item other noncurrent liabilities. Refer to Note 5 for additional information related to the composition of our derivatives portfolio.
December 31, 2021
Level 1 Level 2 Level 3
Other3
Netting
Adjustment
4
Fair Value
Measurements
Assets:          
Equity securities with readily determinable values1
$ 2,372  $ 230  $ 17  $ 104  $ —  $ 2,723 
Debt securities1
—  1,556  33  —  —  1,589 
Derivatives2
69  588  —  —  (459)
6
198 
8
Total assets $ 2,441  $ 2,374  $ 50  $ 104  $ (459) $ 4,510 
Liabilities:          
Contingent consideration liability $ —  $ —  $ 590 
5
$ —  $ —  $ 590 
Derivatives2
—  96  —  —  (82)
7
14 
8
Total liabilities $ —  $ 96  $ 590  $ —  $ (82) $ 604 
1Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
2Refer to Note 5 for additional information related to the composition of our derivatives portfolio.
3Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
4Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.
5Refer to Note 2 for additional information related to the contingent consideration liability resulting from the fairlife acquisition.
6The Company was obligated to return $331 million in cash collateral it had netted against its derivative position.
7The Company did not have the right to reclaim any cash collateral it had netted against its derivative position.
8The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $198 million in the line item other noncurrent assets and $14 million in the line item other noncurrent liabilities. Refer to Note 5 for additional information related to the composition of our derivatives portfolio.
Gains and losses on assets measured at fair value on a nonrecurring basis
The gains and losses on assets measured at fair value on a nonrecurring basis are summarized in the following table (in millions):
Gains (Losses)  
Year Ended December 31, 2022   2021  
Assets held for sale $   $ (266)
4
Other-than-temporary impairment charges (96)
1
— 
Impairment of intangible assets (57)
2
(78)
5
Valuation of shares in equity method investee (24)
3
— 
Total $ (177)   $ (344)
1The Company recorded an other-than-temporary impairment charge of $96 million during the year ended December 31, 2022 related to an equity method investee in Russia. This impairment charge was derived using Level 3 inputs and was primarily driven by revised projections of future operating results.
2During the year ended December 31, 2022, the Company recorded an impairment charge of $57 million related to a trademark in Asia Pacific, which was primarily driven by a change in brand strategy resulting in revised projections of future operating results for the trademark. The fair value of this trademark was derived using discounted cash flow analyses based on Level 3 inputs.
3During the year ended December 31, 2022, we recognized a net loss of $24 million on assets measured at fair value on a nonrecurring basis. The net loss was recorded as a result of an equity method investee issuing additional shares of its stock. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment. This net loss was determined using Level 2 inputs and primarily resulted from the recognition of cumulative translation losses.
4The Company is required to record assets and liabilities that are held for sale at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. The Company recorded charges of $266 million in the line item other income (loss) — net in our consolidated statement of income related to the restructuring of our manufacturing operations in the United States. These charges, which were calculated based on Level 3 inputs, primarily impacted the line item property, plant and equipment in our consolidated balance sheet.
5The Company recorded an impairment charge of $78 million related to a trademark in Europe, which was driven by a change in the long-term outlook on the licensing arrangement for a certain brand. The fair value of this trademark was derived using discounted cash flow analyses based on Level 3 inputs.
Summary of the levels within the fair value hierarchy of pension plan assets
The following table summarizes the levels within the fair value hierarchy for our pension plan assets (in millions):
December 31, 2022 December 31, 2021
Level 1 Level 2 Level 3 Other
1
Total Level 1 Level 2 Level 3 Other
1
Total
Cash and cash equivalents $ 146  $ 489  $   $   $ 635  $ 479  $ 26  $ —  $ —  $ 505 
Equity securities:    
U.S.-based companies 1,157  7  24    1,188  2,382  22  27  —  2,431 
International-based companies 920  16  3    939  1,684  22  —  —  1,706 
Fixed-income securities:
Government bonds 91  1,147      1,238  —  677  —  —  677 
Corporate bonds and debt
   securities
  469  30    499  —  994  29  —  1,023 
Mutual, pooled and commingled
   funds
35  202    530 
4
767  36  283  —  531 
4
850 
Hedge funds/limited
   partnerships
      936 
5
936  —  —  —  720 
5
720 
Real estate       424 
6
424  —  —  —  389 
6
389 
Derivative financial instruments   (14)
2
    (14) —  (9)
2
—  —  (9)
Other     300 
3
246 
7
546  —  —  283 
3
330 
7
613 
Total $ 2,349  $ 2,316  $ 357  $ 2,136  $ 7,158  $ 4,581  $ 2,015  $ 339  $ 1,970  $ 8,905 
1Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 13.
2This class of assets includes investments in interest rate contracts, credit contracts and foreign exchange contracts.
3Includes purchased annuity insurance contracts.
4This class of assets includes actively managed emerging markets equity funds and a collective trust fund for qualified plans, invested primarily in equity securities of companies in developing and emerging markets. There are no liquidity restrictions on these investments.
5This class of assets includes hedge funds that can be subject to redemption restrictions, ranging from monthly to semiannually, with a redemption notice period of up to one year and/or initial lock-up periods of up to three years, and private equity funds that are primarily closed-end funds in which the Company’s investments are generally not eligible for redemption. Distributions from these private equity funds will be received as the underlying assets are liquidated or distributed.
6This class of assets includes funds invested in real estate, including a privately held real estate investment trust, a real estate commingled pension trust fund, infrastructure limited partnerships and commingled investment funds. These funds seek current income and capital appreciation and can be subject to redemption restrictions, ranging from quarterly to semiannually, with a redemption notice period of up to 90 days.
7Primarily includes segregated portfolios of private investment funds that are invested in a portfolio of insurance-linked securities. These assets can be subject to a semiannual redemption, with a redemption notice period of 90 days, subject to certain gate restrictions.
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
The following table provides a reconciliation of the beginning and ending balance of Level 3 assets for our U.S. and non-U.S. pension plans (in millions):
Equity
Securities
Fixed-Income Securities
Other1
Total
2021        
Balance at beginning of year $ $ 31  $ 302  $ 337 
Actual return on plan assets 21  (3) (6) 12 
Purchases, sales and settlements — net (2)
Transfers into Level 3 — net —  (6) —  (6)
Net foreign currency translation adjustments —  —  (11) (11)
Balance at end of year $ 27  $ 29  $ 283  $ 339 
2022      
Balance at beginning of year $ 27  $ 29  $ 283  $ 339 
Actual return on plan assets (12) 1  5  (6)
Purchases, sales and settlements — net (1) 4    3 
Transfers into Level 3 — net 13  (4)   9 
Other —  —  27  27 
Net foreign currency translation adjustments     (15) (15)
Balance at end of year $ 27  $ 30  $ 300  $ 357 
1Includes purchased annuity insurance contracts.
Summary of the fair value of postretirement benefit plan assets
The following table summarizes the levels within the fair value hierarchy for our other postretirement benefit plan assets (in millions):
December 31, 2022 December 31, 2021
Level 1 Level 2
Other 1
Total Level 1 Level 2
Other 1
Total
Cash and cash equivalents $ 35  $ 8  $   $ 43  $ 32  $ $ —  $ 33 
Equity securities:    
U.S.-based companies 133      133  183  —  184 
International-based companies 4      4  12  —  —  12 
Fixed-income securities:  
Government bonds   12    12  —  — 
Corporate bonds and debt securities   71    71  —  82  —  82 
Mutual, pooled and commingled funds   83  3  86  —  85  87 
Hedge funds/limited partnerships     14  14  —  — 
Real estate     6  6  —  — 
Other     4  4  —  — 
Total $ 172  $ 174  $ 27  $ 373  $ 227  $ 172  $ 20  $ 419 
1Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 13